Total Payments
$55,143
2024 Payments
$30,552
Companies
63
Transactions
469
Medicare Patients
4,892
Medicare Billing
$396,725
Payment Breakdown by Category
Other$31,829 (57.7%)
Food & Beverage$11,289 (20.5%)
Travel$5,508 (10.0%)
Consulting$5,248 (9.5%)
Education$1,270 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,450 | 11 | 38.9% |
| Food and Beverage | $11,289 | 391 | 20.5% |
| Honoraria | $10,379 | 10 | 18.8% |
| Travel and Lodging | $5,508 | 36 | 10.0% |
| Consulting Fee | $5,248 | 6 | 9.5% |
| Education | $1,270 | 15 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $17,593 | 51 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $9,311 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,276 | 41 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,583 | 14 | $0 (2024) |
| Lilly USA, LLC | $2,987 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,220 | 19 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $1,657 | 1 | $0 (2024) |
| AstraZeneca UK Limited | $1,365 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $655.55 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $624.54 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,552 | 152 | Daiichi Sankyo Inc. ($16,429) |
| 2023 | $5,452 | 106 | Lilly USA, LLC ($2,791) |
| 2022 | $7,188 | 104 | GlaxoSmithKline, LLC. ($2,496) |
| 2021 | $11,951 | 107 | Karyopharm Therapeutics Inc. ($7,541) |
All Payment Transactions
469 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TALVEY, TECVAYLI | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.67 | General |
| Category: Hematology/Oncology | ||||||
| 12/06/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: HORMONE THERAPY | ||||||
| 12/02/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $128.13 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $84.99 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Oncology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 11/19/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Honoraria | Cash or cash equivalent | $1,656.71 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2024 | Azurity Pharmaceuticals, Inc. | VIVIMUSTA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $26.42 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,430 | 10,029 | $424,683 | $179,007 |
| 2022 | 36 | 2,425 | 32,764 | $540,921 | $215,640 |
| 2021 | 2 | 37 | 38 | $4,610 | $2,078 |
Total Patients
4,892
Total Services
42,831
Medicare Billing
$396,725
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 26 | 3,420 | $119,700 | $62,178 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 670 | $121,940 | $50,091 | 41.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 32 | 103 | $30,797 | $8,566 | 27.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 318 | 783 | $21,141 | $8,033 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 68 | $17,340 | $7,810 | 45.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 349 | 1,014 | $14,196 | $7,664 | 54.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 296 | 761 | $5,327 | $5,200 | 97.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 119 | 288 | $10,368 | $3,824 | 36.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 57 | 98 | $7,154 | $2,817 | 39.4% |
| 83550 | Iron binding capacity | Office | 2023 | 121 | 295 | $6,490 | $2,513 | 38.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 94 | 161 | $6,279 | $2,354 | 37.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 30 | 54 | $5,778 | $2,219 | 38.4% |
| 83540 | Iron level | Office | 2023 | 121 | 294 | $4,704 | $1,853 | 39.4% |
| 82746 | Folic acid level, serum | Office | 2023 | 66 | 122 | $4,392 | $1,745 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 36 | $4,788 | $1,661 | 34.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 24 | 83 | $3,984 | $1,550 | 38.9% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 13 | 13 | $3,692 | $1,482 | 40.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 76 | 167 | $6,179 | $1,452 | 23.5% |
| 80400 | Hormonal panel for adrenal gland assessment (adrenal gland insufficiency) | Office | 2023 | 12 | 28 | $2,520 | $895.16 | 35.5% |
| 83735 | Magnesium level | Office | 2023 | 46 | 132 | $3,036 | $867.24 | 28.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $960.00 | $863.16 | 89.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 31 | 52 | $2,184 | $855.92 | 39.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 49 | $3,332 | $488.96 | 14.7% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 11 | 26 | $2,288 | $440.58 | 19.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $448.00 | $356.44 | 79.6% |
About Jan Davis, APRN
Jan Davis, APRN is a Registered Nurse First Assistant healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821171786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jan Davis, APRN has received a total of $55,143 in payments from pharmaceutical and medical device companies, with $30,552 received in 2024. These payments were reported across 469 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,450).
As a Medicare-enrolled provider, Davis has provided services to 4,892 Medicare beneficiaries, totaling 42,831 services with total Medicare billing of $396,725. Data is available for 3 years (2021–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse First Assistant
- Other Specialties Acute Care
- Location Ogden, UT
- Active Since 10/23/2006
- Last Updated 01/14/2010
- Taxonomy Code 163WR0006X
- Entity Type Individual
- NPI Number 1821171786
Products in Payments
- Enhertu (Drug) $16,716
- XPOVIO (Drug) $9,311
- ENHERTU (Biological) $6,425
- BLENREP (Biological) $4,525
- CAMCEVI (Drug) $1,657
- ENHERTU (Drug) $778.00
- IMBRUVICA (Drug) $500.47
- BRUKINSA (Drug) $455.75
- DARZALEX (Biological) $442.60
- LYNPARZA (Drug) $427.18
- Udenyca (Biological) $366.44
- REBLOZYL (Biological) $233.75
- ORGOVYX (Drug) $228.46
- KEYTRUDA (Biological) $226.84
- SARCLISA (Biological) $226.00
- AVASTIN (Drug) $215.15
- Lenvima (Drug) $204.57
- IMFINZI (Biological) $166.12
- JAKAFI (Drug) $161.23
- LIBTAYO (Biological) $160.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.